Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function

OBJECTIVE: To investigate the effect of 4 weeks of treatment with liraglutide on insulin dose and glycemic control in type 1 diabetic patients with and without residual β-cell function. RESEARCH DESIGN AND METHODS: Ten type 1 diabetic patients with residual β-cell function (C-peptide positive) and 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kielgast, Urd, Krarup, Thure, Holst, Jens Juul, Madsbad, Sten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120168/
https://www.ncbi.nlm.nih.gov/pubmed/21593296
http://dx.doi.org/10.2337/dc11-0096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120168/
https://www.ncbi.nlm.nih.gov/pubmed/21593296
http://dx.doi.org/10.2337/dc11-0096

Ejemplares similares